(Q34722365)

4 August 2017

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

Brauch H

1

1 reference

4 August 2017

Kishida T

2

1 reference

4 August 2017

Glavac D

3

1 reference

4 August 2017

Chen F

4

1 reference

4 August 2017

Pausch F

5

1 reference

4 August 2017

Höfler H

6

1 reference

4 August 2017

Latif F

7

1 reference

4 August 2017

Lerman MI

8

1 reference

4 August 2017

Zbar B

9

1 reference

4 August 2017

Neumann HP

10

1 reference

4 August 2017

1 May 1995

1 reference

4 August 2017

1 reference

4 August 2017

95

1 reference

4 August 2017

551-556

1 reference

4 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00223868

4 August 2017

0 references

cites work

Mutation and cancer: statistical study of retinoblastoma

1 reference

12 December 2020

Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus

1 reference

12 December 2020

Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome

1 reference

12 December 2020

Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p.

1 reference

12 December 2020

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

1 reference

12 December 2020

Renal pathology in von Hippel-Lindau disease

1 reference

12 December 2020

Specific genetic change in tumors associated with von Hippel-Lindau disease

1 reference

12 December 2020

Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa

1 reference

12 December 2020

Clinical features and natural history of von Hippel-Lindau disease

1 reference

12 December 2020

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

1 reference

12 December 2020

Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus

1 reference

12 December 2020

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

1 reference

12 December 2020

Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype

1 reference

12 December 2020

von Hippel-Lindau disease affecting 43 members of a single kindred

1 reference

12 December 2020

Three tetrameric repeat polymorphisms on human chromosome 3: D3S1349; D3S1350; D3S1351.

1 reference

12 December 2020

LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.

1 reference

12 December 2020

Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland

1 reference

12 December 2020

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

12 December 2020

Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

1 reference

12 December 2020

Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.

1 reference

12 December 2020

Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00223868

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference